毛细管气相色谱法测定速效伤风胶囊中对乙酰氨基酚、咖啡因、马来酸氯苯那敏的含量

用５％Ｐｈ－Ｍｅ－Ｓｉｌｉｃｏｎｅ毛细管色谱柱，ＦＩＤ，二阶程序升温，以正十六烷作为内标物测定速效伤风胶囊中对乙酰氨基酚、咖啡因、马来酸氯苯那敏的含量。浓度线性范围：对乙酰氨基酚４～２０ｇ／Ｌ，咖啡因０．０８４～０．４２ｇ／Ｌ，马来酸氯苯那敏０．１５～０．７５ｇ／Ｌ。平均回收率（ｎ＝５）：对乙酰氨基酚９９．６２％（ＲＳＤ＝０．４４％）咖啡因９６．４６％（ＲＳＤ＝１．３２％），马来酸氯苯那敏９８．５５％（ＲＳＤ＝０．６５％）。     

毛细管气相色谱法测定速效伤风胶囊中对乙酰氨基酚、咖啡因、马来酸氯苯那敏的含量

 用５％Ｐｈ－Ｍｅ－Ｓｉｌｉｃｏｎｅ毛细管色谱柱，ＦＩＤ，二阶程序升温，以正十六烷作为内标物测定速效伤风胶囊中对乙酰氨基酚、咖啡因、马来酸氯苯那敏的含量。浓度线性范围：对乙酰氨基酚４～２０ｇ／Ｌ，咖啡因０．０８４～０．４２ｇ／Ｌ，马来酸氯苯那敏０．１５～０．７５ｇ／Ｌ。平均回收率（ｎ＝５）：对乙酰氨基酚９９．６２％（ＲＳＤ＝０．４４％）咖啡因９６．４６％（ＲＳＤ＝１．３２％），马来酸氯苯那敏９８．５５％（ＲＳＤ＝０．６５％）。     

高效液相色谱法测定非诺贝特含量

以甲醇－水（９５：５,Ｖ／Ｖ）为流动相,用ＯＤＳ柱以高效液相色谱法测定非诺贝特含量。紫外检测波长为２８６ｎｍ。非诺贝特在浓度为０．０４－０．２０ｇ／Ｌ间线线性关系良好。重复进样ＲＳＤ＝０．１４％,最低检出浓度为０．１０ｍｇ／Ｌ,平均回收率为９９．６６％。     

荧光光度法测定环境水中微量甲基对硫磷

研究了荧光分光光度法测定环境水中甲基对硫磷的一。在吲哚丙酮溶液０．２５％，过硼酸钠溶液０．２５％溶液中，温度５℃、λｅｘ／λｅｍ＝４１０ｎｍ／４９０ｎｍ，检出限５．０（５．２）μｇ／Ｌ，线性范围０－２．０（２．６）ｍｇ／Ｌ，回收率达９８－１０２％，结果满意。     

高效液相色谱法测定人血清中头孢克罗

建立了测定人血清中头孢克罗的高效液相色谱法。分析柱为Ｓｈｉｍ－ｐａｃｋＣＬＣ－ＯＤＳ（５μｍ）,６．０ｍｍ×１５０ｍｍ;流动相为磷酸盐缓冲液（ｐＨ５．８）∶乙腈＝８７．５∶１２．５,流速为１．２ｍＬ／ｍｉｎ;紫外检测波长为２５４ｎｍ。血清中头孢克罗浓度在０．１２５～２４ｍｇ／Ｌ范围内,峰高与浓度呈良好的线性关系,回归方程为Ｈ＝－３．２００＋９２．２９Ｃ（ｎ＝９,ｒ＝０．９９９９）,日内、日间变异系数分别为４．１％和５．８％,平均回收率为９９．３％。     

HPLC法测定中成药制剂中10-羟基-2-癸烯酸的含量

采用ＳｐｈｅｒｉｓｏｒｂＣ１８柱,以甲醇∶水∶磷酸（４５∶６５∶０．５）为流动相,以ＵＶ２１０ｎｍ为检测波长,测定中成药制剂中１０－羟基－２－癸烯酸（１０－ＨＤＡ）的含量,１０－ＨＤＡ浓度在０．００６～０．０３０ｇ／Ｌ范围内线性关系良好（ｒ＝０．９９９９,ｎ＝５）,检测限为０．２ｍｇ／Ｌ（Ｓ／Ｎ＝３∶１）。方法具有定量准确、快速及主峰和杂质分离度高等特点。     

气相色谱/质谱法测定大鼠脑中5-羟色胺的含量

采用气相色谱／质谱法（ＧＣ／ＭＳ）测定了正常大鼠和服药大鼠脑组织中５－羟色胺（５－ＨＴ）的浓度。大鼠脑组织制成匀浆后,先将５－ＨＴ酰化,酰化物经乙酸乙酯提取后,再经七氟丁酸酐衍生化,用ＧＣ／ＭＳ测定。ＭＳ采用电子捕获负离子化学电离（ＥＣＮＩＣＩ）模式。方法的线性范围为０．５０～５０．０μｇ／Ｌ,回归方程为Ｙ＝０．１３４８Ｘ－０．０７９９５（ｒ＝０．９９９６）;平均回收率为９８．２％±３．８％（ｎ＝１０）;检测限为０．５μｇ／Ｌ;相对标准偏差小于１０％。     

吲哚乙酸与磷钼黄反应及其极谱分析的研究

在ＮＨ３－ＮＨ４Ｃｌ缓冲溶液中（ｐＨ＝９．５），吲哚乙酸与磷钼黄的还原产物在滴汞电极上于－１．１０Ｖ（ｖｓ．ＳＣＥ）处产生一灵敏的极谱波，该波波高与吲哚乙酸的浓度在１．０×１０－７－５．０×１０－６ｍｏｌ／Ｌ范围内成线性关系，检测下限为５．０×１０－８ｍｏｌ／Ｌ。如在上述还原产物中加入偶氮胭脂红Ｂ、孔雀绿、甲基紫等染料及聚乙烯醇，可使极谱波的灵敏度提高，使吲哚乙酸的浓度在５．０×１０－８－１．０×１０－６ｍｏｌ／Ｌ范围内与波高成线性关系，检测下限降低至１．０×１０－８ｍｏｌ／Ｌ。     

测定玻璃体和房水中维拉帕米含量的高效液相色谱法

研究了用ＨＰＬＣ 测定兔眼玻璃体和房水中维拉帕米含量的方法。用丙咪嗪为内标， 采用Ｓｐｈｅｒｉｃａｌ Ｃ１８色谱柱分离， 以甲醇－ ０ ．０４ ｍｏｌ／Ｌ 醋酸铵－ 乙腈－ 二乙胺（ 体积比１ ∶１ ∶０ ．５ ∶０ ．０２） 为流动相， 检测波长为２７８ｎｍ 。样品用正己烷－ 异丁醇提取后进样， 分析速度快。 样品及内标的保留时间分别为４ ．６３ ｍｉｎ 及９ ．２３ ｍｉｎ ； 线性范围为２ ．５ ～１００ ｍｇ／Ｌ， 相关系数ｒ 为０ ．９９９ ７ 。方法的回收率为１００ ．３ ％ （ ｎ ＝ ５） ，ＲＳＤ 为３ ．６３％ ， 日内ＲＳＤ 为０ ．５ ％ ～３ ．６１ ％ ， 日间ＲＳＤ 为３ ．７５ ％ ～４ ．８０ ％ ， 最低检测质量浓度为０．２５ ｍｇ／ Ｌ。 应用该法测定了创伤家兔玻璃体和房水中维拉帕米浓度的变化。     

高效液相色谱法测定灭尔痛片的组分含量

采用高效液相色谱法同时测定灭尔痛片中对乙酰氨基酚、异丙基安替比林、及咖啡因３种成分的含量。色谱条件为：ＯＤＳ柱，甲醇＋水（６０＋４０）为流动相，检测波长为２５４ｎｍ。方法线性范围分别为：２４～１２０ｍｇ／Ｌ（ｒ＝０９９７６）；１２～６０ｍｇ／Ｌ（ｒ＝０９９９４）；４～２０ｍｇ／Ｌ（ｒ＝０９９９４）。各组分的平均回收率（ｎ＝６）分别为：１００３％，ＲＳＤ＝０４２％；９９７％，ＲＳＤ＝０６９％；９９２％，ＲＳＤ＝０４６％。该法操作简便、快捷，结果准确。     

高效液相色谱-荧光检测法测定血浆中总同型半胱氨酸

 建立了测定血浆中总同型半胱氨酸的柱前衍生、高效液相色谱-荧光检测的分析方法。以Br omobimane作荧光剂,对巯基进行衍生。同型半胱氨酸的最低检测浓度为0.5 μmol/L,线性 浓度范围是2.5～80.0 μmol/L,回收率为94.0%～112.0%,批内、批间相对标准偏差都小于5. 6%。 关键词：     

对小鼠血清中乳梨醇含量的测定

建立了测定小鼠血清中乳梨醇的含量的高效液相色谱法。分析柱为ＷａｔｅｒｓＳｕｇａｒ－Ｐａｋｌ（钙型）柱,流动相为重蒸水,柱温９０℃,采用示差折光检测器检测定量。回收率为９８．６％,方法的最低检测限为０．１μｇ（Ｓ／Ｎ＝３．７５）,在０～６００ｍｇ／Ｌ的范围内呈良好的线性关系,ｒ＝０．９９９２,日内和日间ＲＳＤ均小于１．０％（ｎ＝５）。     

Solid phase extraction of oxcarbazepine and its metabolites from plasma for analysis by high performance liquid chromatography.

A rapid, sensitive and simple-to-operate high performance liquid chromatographic method for the simulataneous determination of oxcarbazepine, 10-hydroxycarbazepine and 10,11-dihydro-10,11-trans-dihydroxy-carbamazepine in plasma is described. The drug and its metabolites were extracted from plasma using commercially available reversed phase octadecylsilane bonded-silica columns (Bond Elut C18, 1 mL capacity). Chromatographic separation of oxcarbazepine and its metabolites was achieved using a mobile phase consisting of acetonitrile/methanol/water (13:25:62 by volume) at a flow rate of 1.2 mL/min in conjunction with a Waters Associates Nova-Pak C18 column. The analytical column, in Radial-Pak cartridge form, was used in combination with a LiChrospher 5 microns C18 guard column. By measuring the UV absorbance at 214 nm, plasma levels in the region of 50-100 ng/mL for the drug and its metabolites can be detected with only 100 microL of plasma. The method has been applied to pharmacokinetic studies of oxcarbazepine and its metabolites in children with epilepsy; preliminary pharmacokinetic findings in two patients at steady-state are presented.     

高效液相色谱法测定人脑脊液中γ-氨基丁酸和谷氨酸

研究了丹酰氯柱前衍生反相高效液相色谱法测定人脑脊液中γ－氨基丁酸（Ｇａｂａ）和谷氨酸（Ｇｌｕ）的方法。检测波长为ＵＶ２５４ｎｍ;流动相Ａ：甲醇;流动相Ｂ：四氢呋喃－甲醇－０．０５ｍｏｌ／Ｌ醋酸钠（ｐＨ６．２）（５７５４２０,Ｖ／Ｖ）;流速为１ｍＬ／ｍｉｎ;梯度洗脱。讨论了有关测试条件。方法的线性范围分别为５～１０００μｍｏｌ／Ｌ（Ｇｌｕ）和１～６００μｍｏｌ／Ｌ（Ｇａｂａ）;最低检出限（μｍｏｌ／Ｌ）分别为０．００２（Ｇｌｕ）和０．００１（Ｇａｂａ）。     

Development and validation of HPLC method for the determination of α-tocopherol in human erythrocytes for clinical applications

In this work, a simple isocratic reversed-phase HPLC method for determination of alpha-tocopherol in human erythrocytes has been developed and validated. After separation of plasma the erythrocytes were washed three times with 0.9% sodium chloride containing 0.01% butylated hydroxytoluene (BHT) as antioxidant and then were diluted 1:1 (v/v) with the same solution. In the liquid-liquid extraction (LLE) procedure, 2500 microL of n-hexane was added to 500 microL of erythrocytes. After 2 min this mixture was deproteinized by addition of cool ethanol (500 microL, 5 min) denatured with 5% methanol containing alpha-tocopherol acetate (20 micromol L(-1)), as internal standard, and then extracted for 5 min by vortex mixing. After centrifugation (10 min, 1600xg) an aliquot (2000 microL) of the clean extract was separated and evaporated under nitrogen. The residue was dissolved in 400 microL methanol and analysed by reversed-phase HPLC on a 4.6 mmx150 mm, 5 microm Pecosphere C18 column; the mobile phase was 100% methanol, flow rate 1.2 mL min(-1). The volume injected was 100 microL and detection was by diode-array detector at a wavelength of 295 nm. The extraction recovery of alpha-tocopherol from human erythrocytes was 100.0+/-2.0%. The detection limit was 0.1 micromol L(-1) and a linear calibration plot was obtained in the concentration range 0.5-20.0 micromol L(-1). Within determination precision was 5.2% RSD (n=10), between determination precision was 6.1% RSD (n=10). The method was applied successfully in a clinical study of patients with acute pancreatitis and for determination of the reference values in the healthy Czech population.     

A rapid HPLC method with fluorometric detection for determination of plasma itraconazole and hydroxy-itraconazole concentrations in cystic fibrosis children with allergic bronchopulmonary aspergillosis

The development and validation of a simple, rapid and selective high-performance liquid chromatography (HPLC) method is described for the quantitation of itraconazole and hydroxy-itraconazole in 100 microL of plasma from a paediatric population. The mobile phase of methanol (75% v/v) and water (25% v/v) was pumped at 1 mL/min through a C18 Symmetry (3.9 mm i.d. x 150 mm) cartridge. Using a protein-precipitation method, 100 microL internal standard (IS) solution (R051012, 555 microg/L in acetonitrile) were added to 100 microL of plasma followed by 10 microL zinc sulphate solution (20% w/v). Itraconazole, hydroxy-itraconazole and IS eluted at 4.7, 8.3 and 12.5 min, respectively and were detected fluorometrically at 250 nm (excitation) and 380 nm (emission). Recoveries were 87.1-96.7%. Calibrations in drug-free plasma were linear (r2 > 0.99) from 50 to 2000 microg/L, using 1/c2 (c = concentration) weighting. Intraday and interday imprecision (CV%) was 4.8-17.3 and 6.3-16.6% for itraconazole, and 4.6-17.9 and 7.02-18.4% for hydroxy-itraconazole. Inaccuracy was -7.1 to -14.7% for itraconazole and -0.1 to -9.7% for hydroxy-itraconazole. The clinical application of this method was demonstrated by measurement of itraconazole and hydroxy-itraconazole in plasma samples drawn from paediatric cystic fibrosis patients, who were prescribed itraconazole for treatment of allergic bronchopulmonary aspergillosis.     

高效液相色谱法测定血清中头孢噻肟浓度

用固相萃取法处理样品,以扑热息痛为内标物、甲醇－醋酸钠／醋酸缓冲溶液作流动相,采用反相高效液相色谱法测定血清中头孢噻肟的浓度。头孢噻肟和内标物的平均回收率分别为９６．７％和９７．７％,头孢噻肟血清浓度在１０ｍｇ／Ｌ至１５０ｍｇ／Ｌ范围内有良好线性关系,最低检测浓度为２ｍｇ／Ｌ,日内和日间相对标准偏差分别在３．０％和４．１％以内。结果表明方法准确、简便。     

纳米纤维固相萃取-高效液相色谱法测定血浆中的5-羟色胺

基于纳米纤维的富集作用,建立了血浆中5-羟色胺(5-HT)的柱前衍生高效液相色谱-电化学检测(HPLC-ECD)分析方法.用10%(v/v)高氯酸溶液沉淀血浆蛋白,离心后取上清液,用0.1 mol/L 的四苯硼酸钠溶液调节pH值至8.5,加入衍生剂邻苯二甲醛溶液于30 ℃衍生4 min,经纳米纤维固相萃取柱净化富集后,...     

手性荧光衍生化反相高效液相法分离肾上腺素对映体

 以R (- ) /S (+) 4 (N ,N dimethylaminosulfonyl) 7 (3 iso thiocyanatopyrrolidino) 2 ,1,3 benzoxadiazole(DBD PyNCS)为手性荧光衍生化试剂 ,用反相高效液相法 (RP HPLC)对 DL 肾上腺素对映体进行分离。衍生化反应是在含有 7%吡啶的溶剂中 ,6 5℃温度条件下反应 35min ,生成具有荧光特性的肾上腺素非对映体衍生物(λex=4 6 0nm ,λem=5 5 0nm)。生成的非对映体衍生物在流动相为乙腈 水 (体积比为 2 8∶72 ) ,流速为 1 0mL/min时 ,在DiamonsilTMC18柱 (15 0mm× 4 6mmi d ,5 μm)上分离度可达 2 6。     

Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Fludarabine and cyclophosphamide are anticancer agents mainly used in the treatment of hematologic malignancies. We have developed and validated an assay using high-performance liquid chromatography (HPLC) coupled with electrospray ionization tandem mass spectrometry for the quantification of fludarabine in combination with cyclophosphamide in human heparin and human EDTA plasma. Sample pre-treatment consisted of a protein precipitation with cold acetonitrile (-20 degrees C) using 250 microL of plasma. Separation was performed on an Extend C18 column (150 x 2.1 mm i.d.; 5 microm) with a stepwise gradient using 1 mM ammonia solution and acetonitrile at a flow rate of 400 microL/min. The analytical run time was 12 min. The triple quadrupole mass spectrometer was operated in the positive ion mode and multiple reaction monitoring was used for drug quantification. The method was validated over a concentration range of 1 to 100 ng/mL for fludarabine and cyclophosphamide in human heparin and human EDTA plasma. The coefficients of variation were <13.9% for inter- and intra-day precisions. Mean accuracies were also within the designated limits (+/-15%). The analytes were stable in plasma, processed extracts and in stock solution under all relevant conditions.